Matches in Wikidata for { <http://www.wikidata.org/entity/Q61627994> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q61627994 description "artículu científicu espublizáu en setiembre de 2012" @default.
- Q61627994 description "im September 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61627994 description "scientific article published on 01 September 2012" @default.
- Q61627994 description "wetenschappelijk artikel" @default.
- Q61627994 description "наукова стаття, опублікована у вересні 2012" @default.
- Q61627994 name "A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma" @default.
- Q61627994 name "A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma" @default.
- Q61627994 type Item @default.
- Q61627994 label "A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma" @default.
- Q61627994 label "A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma" @default.
- Q61627994 prefLabel "A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma" @default.
- Q61627994 prefLabel "A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma" @default.
- Q61627994 P1433 Q61627994-2B20E2A1-FAFE-4075-9BE7-EDA53A9B471B @default.
- Q61627994 P1476 Q61627994-A4C7F224-0053-4ACC-BF09-718BCDFAF0A3 @default.
- Q61627994 P2093 Q61627994-192DD63F-6F5F-4398-B00B-B8344D4ADB01 @default.
- Q61627994 P2093 Q61627994-21A671B5-5F83-4E5C-866B-5AF5A980F800 @default.
- Q61627994 P2093 Q61627994-2E0BD7D9-E856-4D33-80EA-A6A97B2DC6E8 @default.
- Q61627994 P2093 Q61627994-351488B7-2FDA-4BE1-B163-61FF4C483425 @default.
- Q61627994 P2093 Q61627994-39B823BA-B3E0-4FD9-A958-66F217584D14 @default.
- Q61627994 P2093 Q61627994-A67CDDA4-99D6-4D9B-A57F-5E42B87F0AE1 @default.
- Q61627994 P304 Q61627994-DD2360AD-0800-432A-BF67-D31153E9CB1F @default.
- Q61627994 P31 Q61627994-A9968F80-A8A5-4AFC-AA36-3880A834D729 @default.
- Q61627994 P356 Q61627994-02AF61E9-13BB-4951-8250-42251399BB94 @default.
- Q61627994 P433 Q61627994-845C4F45-A6F0-4FA1-AFCF-8D63A1F424F4 @default.
- Q61627994 P478 Q61627994-A5F88367-0EFE-477A-A467-7BB6FF9058E7 @default.
- Q61627994 P50 Q61627994-135387C8-5C92-4E9D-996C-15283F1E5589 @default.
- Q61627994 P50 Q61627994-514DC960-4A2A-43A3-A276-A119220FADB2 @default.
- Q61627994 P50 Q61627994-68A6FA25-A4CA-4432-BAB9-A52C93B676DC @default.
- Q61627994 P50 Q61627994-B1A7C79D-C741-44FC-B6B1-55ACA704F7FE @default.
- Q61627994 P577 Q61627994-CCCE5905-9B52-4F36-A317-73A445401D41 @default.
- Q61627994 P698 Q61627994-993A2302-5B68-4658-A559-82CCAB83266D @default.
- Q61627994 P921 Q61627994-680045DF-D1D9-4D7C-ACED-C5CB1795D615 @default.
- Q61627994 P356 JTO.0B013E31825F22EE @default.
- Q61627994 P698 22895142 @default.
- Q61627994 P1433 Q2448056 @default.
- Q61627994 P1476 "A phase II study of intermittent sunitinib malate as second-line therapy in progressive malignant pleural mesothelioma" @default.
- Q61627994 P2093 "Agatha van der Schaaf" @default.
- Q61627994 P2093 "Amanda Segal" @default.
- Q61627994 P2093 "Arman Hasani" @default.
- Q61627994 P2093 "Ian M Dick" @default.
- Q61627994 P2093 "Michael J Byrne" @default.
- Q61627994 P2093 "Michael J Millward" @default.
- Q61627994 P304 "1449-1456" @default.
- Q61627994 P31 Q13442814 @default.
- Q61627994 P356 "10.1097/JTO.0B013E31825F22EE" @default.
- Q61627994 P433 "9" @default.
- Q61627994 P478 "7" @default.
- Q61627994 P50 Q40897391 @default.
- Q61627994 P50 Q58211989 @default.
- Q61627994 P50 Q86284202 @default.
- Q61627994 P50 Q99566706 @default.
- Q61627994 P577 "2012-09-01T00:00:00Z" @default.
- Q61627994 P698 "22895142" @default.
- Q61627994 P921 Q18557602 @default.